These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38931436)

  • 1. In Vitro Antibiofilm Activity of Fosfomycin Alone and in Combination with Other Antibiotics against Multidrug-Resistant and Extensively Drug-Resistant
    Slade-Vitković M; Batarilo I; Bielen L; Maravić-Vlahoviček G; Bedenić B
    Pharmaceuticals (Basel); 2024 Jun; 17(6):. PubMed ID: 38931436
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Memar MY; Adibkia K; Farajnia S; Samadi Kafil H; Khalili Y; Azargun R; Ghotaslou R
    Iran J Pharm Res; 2021; 20(2):286-296. PubMed ID: 34567162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of ceftolozane/tazobactam, alone and in combination with colistin, against multidrug-resistant Pseudomonas aeruginosa in an in vitro biofilm pharmacodynamic model.
    Gómez-Junyent J; Benavent E; Sierra Y; El Haj C; Soldevila L; Torrejón B; Rigo-Bonnin R; Tubau F; Ariza J; Murillo O
    Int J Antimicrob Agents; 2019 May; 53(5):612-619. PubMed ID: 30682497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time-Kill Evaluation of Antibiotic Combinations Containing Ceftazidime-Avibactam against Extensively Drug-Resistant Pseudomonas aeruginosa and Their Potential Role against Ceftazidime-Avibactam-Resistant Isolates.
    Montero MM; Domene Ochoa S; López-Causapé C; Luque S; Sorlí L; Campillo N; López Montesinos I; Padilla E; Prim N; Angulo-Brunet A; Grau S; Oliver A; Horcajada JP
    Microbiol Spectr; 2021 Sep; 9(1):e0058521. PubMed ID: 34319141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro pharmacokinetics/pharmacodynamics of continuous ceftazidime infusion alone and in combination with colistin against Pseudomonas aeruginosa biofilm.
    Gómez-Junyent J; Murillo O; Yu HH; Azad MAK; Wickremasinghe H; Rigo-Bonnin R; Benavent E; Ariza J; Li J
    Int J Antimicrob Agents; 2021 Feb; 57(2):106246. PubMed ID: 33253904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro killing of multidrug/extensively drug-resistant
    Slade-Vitković M; Bedenić B; Bielen L; Batarilo I; Kibel S; Maravić-Vlahoviček G
    J Chemother; 2023 May; 35(3):219-230. PubMed ID: 35943136
    [No Abstract]   [Full Text] [Related]  

  • 7. Mathematical pharmacodynamic modeling for antimicrobial assessment of ceftazidime/colistin versus gentamicin/meropenem combinations against carbapenem-resistant Pseudomonas aeruginosa biofilm.
    Badawy MSEM; Elkhatib WF; Shebl RI
    Ann Clin Microbiol Antimicrob; 2023 Jul; 22(1):53. PubMed ID: 37394468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of infections caused by multidrug-resistant Gram-negative bacilli: A practical approach by the Italian (SIMIT) and French (SPILF) Societies of Infectious Diseases.
    Meschiari M; Asquier-Khati A; Tiseo G; Luque-Paz D; Murri R; Boutoille D; Falcone M; Mussini C; Tattevin P;
    Int J Antimicrob Agents; 2024 Jul; 64(1):107186. PubMed ID: 38688353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic antibacterial effects of colistin in combination with aminoglycoside, carbapenems, cephalosporins, fluoroquinolones, tetracyclines, fosfomycin, and piperacillin on multidrug resistant Klebsiella pneumoniae isolates.
    Ontong JC; Ozioma NF; Voravuthikunchai SP; Chusri S
    PLoS One; 2021; 16(1):e0244673. PubMed ID: 33406110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic resistance, biofilm production ability and genetic diversity of carbapenem-resistant Pseudomonas aeruginosa strains isolated from nosocomial infections in southwestern Iran.
    Heidari R; Farajzadeh Sheikh A; Hashemzadeh M; Farshadzadeh Z; Salmanzadeh S; Saki M
    Mol Biol Rep; 2022 May; 49(5):3811-3822. PubMed ID: 35169997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Synergy of Ceftazidime-Avibactam in Combination with Meropenem, Amikacin, Aztreonam, Colistin, or Fosfomycin against Well-Characterized Multidrug-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa.
    Mikhail S; Singh NB; Kebriaei R; Rice SA; Stamper KC; Castanheira M; Rybak MJ
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of clarithromycin in combination with other antimicrobial agents against biofilm-forming Pseudomonas aeruginosa strains.
    Kádár B; Szász M; Kristóf K; Pesti N; Krizsán G; Szentandrássy J; Rókusz L; Nagy K; Szabó D
    Acta Microbiol Immunol Hung; 2010 Sep; 57(3):235-45. PubMed ID: 20870595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa.
    Chen YH; Peng CF; Lu PL; Tsai JJ; Chen TP
    Kaohsiung J Med Sci; 2004 Jun; 20(6):261-7. PubMed ID: 15253466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the In Vitro Susceptibility of Ceftolozane-Tazobactam With the Cumulative Susceptibility Rates of Standard Antibiotic Combinations When Tested Against
    Shortridge D; Pfaller MA; Arends SJR; Raddatz J; DePestel DD; Flamm RK
    Open Forum Infect Dis; 2019 Jun; 6(6):ofz240. PubMed ID: 31263733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000).
    Jones RN; Kirby JT; Beach ML; Biedenbach DJ; Pfaller MA
    Diagn Microbiol Infect Dis; 2002 Jul; 43(3):239-43. PubMed ID: 12106958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro investigation of relationship between quorum-sensing system genes, biofilm forming ability, and drug resistance in clinical isolates of Pseudomonas aeruginosa.
    Hemmati J; Nazari M; Abolhasani FS; Ahmadi A; Asghari B
    BMC Microbiol; 2024 Mar; 24(1):99. PubMed ID: 38528442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An
    Sugathan S; Mandal J
    J Med Microbiol; 2019 Dec; 68(12):1699-1706. PubMed ID: 31647407
    [No Abstract]   [Full Text] [Related]  

  • 18. Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against
    Wang L; Di Luca M; Tkhilaishvili T; Trampuz A; Gonzalez Moreno M
    Front Microbiol; 2019; 10():2522. PubMed ID: 31781056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biofilm generation and antibiotic resistant profile of extensive and multidrug resistant
    Akrami S; Ekrami A; Avarvand AY
    Health Sci Rep; 2024 Jun; 7(6):e2138. PubMed ID: 38899004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biofilm formation and antibiotic sensitivity in
    Hu S; Lv Y; Xu H; Zheng B; Xiao Y
    Front Cell Infect Microbiol; 2022; 12():953780. PubMed ID: 35967866
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.